美股市場個股詳情
ALNY 阿里拉姆制藥
- 246.800
- -1.990-0.80%
收盤價 11/21 16:00 (美東)
- 246.800
- 0.0000.00%
盤後 20:01 (美東)
318.32億總市值-94198市盈率TTM
250.710最高價245.320最低價68.73萬股成交量247.460今開248.790昨收1.70億成交額0.54%換手率虧損市盈率(靜)1.29億總股本304.39052周最高983.27市淨率316.98億流通值141.97552周最低--股息TTM1.28億流通股304.390歷史最高--股息率TTM2.17%振幅3.650歷史最低247.820平均價1股每手
關於阿里拉姆制藥公司
Alnylam Pharmaceuticals是RNA干擾(RNAi)治療研究的領導者。RNAi是細胞內一種自然發生的生物通路，用於序列特異性沉默和調控基因表達。Alnylam有5種藥物上市:Onpattro和Amvuttra治療hATTR澱粉樣變，Givlaari治療急性肝卟啉，Oxlumo治療原發性高草酸尿1型，Leqvio治療高膽固醇血癥。它也有幾個不同治療領域的臨牀項目:遺傳藥物;cardio-metabolic疾病;肝臟感染性疾病和中樞神經系統/眼部疾病。來自研究合作伙伴的預付費用提高了Alnylam的現金水平，該公司有望從合作伙伴關係下的藥物商業化中看到更多的里程碑和版稅。
公司介紹
公司代碼ALNY
公司名稱阿里拉姆制藥
上市日期2004/05/27
發行價格6.00
成立日期2002
CEODr. Yvonne L Greenstreet, MB.Ch.B.
所屬市場納斯達克
員工數量2100
年結日12-31
公司地址675 West Kendall Street,Henri A. Termeer Square
城市Cambridge
省份麻塞諸塞州
國家美國
郵編02142
電話1-617-551-8200
董事高管
- 姓名
- 職務
- 年薪
- Dr. Yvonne L Greenstreet, MB.Ch.B.
- Director and Chief Executive Officer
- 889.57萬
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Chief Innovation Officer
- 331.72萬
- Kevin Joseph Fitzgerald, PhD
- Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development
- --
- Dr. Pushkal P. Garg, M.D.
- Chief Medical Officer and Executive Vice President, Development and Medical Affairs
- 323.11萬
- Tolga Tanguler
- Chief Commercial Officer
- 286.97萬
- Jeffrey V. Poulton
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 322.44萬
- Amy W. Schulman
- Chairman of the Board
- 53.14萬
- Michael W. Bonney
- Director
- 46.72萬
- David E.I. Pyott, M.B.A.,M.D.
- Independent Director
- 47.72萬
- Dr. Elliott Sigal, M.D.,PhD
- Independent Director
- 47.01萬
- Dr. Carolyn R. Bertozzi, PhD
- Independent Director
- 66.89萬
- Dr. Phillip A. Sharp,PhD
- Independent Director
- 50.22萬
- Dr. Olivier Raymond Brandicourt, M.D.
- Independent Director
- 48.10萬
- Dr. Margaret A. Hamburg, M.D.
- Independent Director
- 47.14萬
- Dr. Dennis A. Ausiello, M.D.
- Independent Director
- 47.72萬
- Colleen F. Reitan
- Independent Director
- 48.92萬
- Peter N. Kellogg
- Independent Director
- 65.87萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據